Human herpesvirus 7 primary infection in kidney transplant recipients

Transplantation

Volumn 85, Issue 2, 2008, Pages 298-302

  Antón, Andrés ^a   Cervera, Carlos ^a   Pumarola, Tomás ^a   Moreno, Asunción ^a   Benito, Natividad ^a   Linares, Laura ^a   Esteva, Cristina ^a   Cofán, Federico ^a   Jiménez De Anta, María Teresa ^a   Marcos, María Ángeles ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Adult solid organ transplantation; Human herpesvirus 7 primary infection; Quantitative polymerase chain reaction

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOFLUORESCENCE TEST; KIDNEY GRAFT; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS LOAD;

ANTIBODIES, VIRAL; COHORT STUDIES; DNA, VIRAL; FOLLOW-UP STUDIES; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; SPAIN; VIRAL LOAD;

EID: 38549102473     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181601413     Document Type: Article

References (26)

1. Frenkel N, Schirmer EC, Wyatt LS, et al. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 1990; 87: 748.
2. Yoshikawa T, Asano Y, Kobayashi I, et al. Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol 1993; 41: 319.
3. Suga S, Yoshikawa T, Nagai T, Asano Y. Clinical features and virological findings in children with primary human herpesvirus 7 infection. Pediatrics 1997; 99: E4.
4. Torigoe S, Koide W, Yamada M, et al. Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 1996; 129: 301.
5. Dockrell DH, Paya CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 2001; 11: 23.
6. Razonable RR, Rivero A, Brown RA, et al. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant 2003; 17: 114.
7. Benito N, Moreno A, Pumarola T, Marcos MA. [Human herpesvirus type 6 and type 7 in transplant recipients.] Enferm Infecc Microbiol Clin 2003; 21: 424.
8. Ljungman P. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis 2002; 186: S99.
9. Mendez JC, Dockrell DH, Espy MJ, et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 2001; 183: 179.
10. Griffiths PD, Ait-Khaled M, Bearcroft CP, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. J Med Virol 1999; 59: 496.
11. Kidd IM, Clark DA, Sabin CA, et al. Prospective study of human beta-herpesviruses after renal transplantation: Association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 2000; 69: 2400.
12. Tong CY, Bakran A, Williams H, et al. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 2000; 70: 213.
13. Chapenko S, Folkmane I, Tomsone V, et al. Co-infection of two beta-herpesviruses (CMV and HHV-7) as an increased risk factor for 'CMV disease' in patients undergoing renal transplantation. Clin Transplant 2000; 14: 486.
14. Hara S, Kimura H, Hoshino Y, et al. Detection of herpesvirus DNA in the serum of immunocompetent children. Microbiol Immunol 2002; 46: 177.
15. Ward KN, Couto Parada X, Passas J, Thiruchelvam AD. Evaluation of the specificity and sensitivity of indirect immunofluorescence tests for IgG to human herpesviruses-6 and -7. J Virol Methods 2002; 106: 107.
16. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 2005; 32: 183.
17. Cervera C, Marcos MA, Linares L, et al. A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients. Transplantation 2006; 82: 979.
18. Thomasini RL, Sampaio AM, Bonon SH, et al. Detection and monitoring of human herpesvirus 7 in adult liver transplant patients: Impact on clinical course and association with cytomegalovirus. Transplant Proc 2007; 39: 1537.
19. Lehto JT, Halme M, Tukiainen P, et al. Human herpesvirus-6 and -7 after lung and heart-lung transplantation. J Heart Lung Transplant 2007; 26: 41.
20. Chan PK, Peiris JS, Yuen KY, et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 1997; 53: 295.
21. Roback JD. CMV and blood transfusions. Rev Med Virol 2002; 12: 211.
22. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355: 1331.
23. Brennan DC, Storch GA, Singer GG, et al. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis 2000; 181: 1557.
24. Galarraga MC, Gomez E, de Ona M, et al. Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplant Proc 2005; 37: 2124.
25. Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 2006; 82: S9.
26. Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005; 192: 1331.